Structure and dynamic regulation of Abl kinases.

J Biol Chem 2013 Feb 11;288(8):5443-50. Epub 2013 Jan 11.

Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15219, USA.

The c-abl proto-oncogene encodes a unique protein-tyrosine kinase (Abl) distinct from c-Src, c-Fes, and other cytoplasmic tyrosine kinases. In normal cells, Abl plays prominent roles in cellular responses to genotoxic stress as well as in the regulation of the actin cytoskeleton. Abl is also well known in the context of Bcr-Abl, the oncogenic fusion protein characteristic of chronic myelogenous leukemia. Selective inhibitors of Bcr-Abl, of which imatinib is the prototype, have had a tremendous impact on clinical outcomes in chronic myelogenous leukemia and revolutionized the field of targeted cancer therapy. In this minireview, we focus on the structural organization and dynamics of Abl kinases and how these features influence inhibitor sensitivity.

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.R112.438382DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581414PMC
February 2013
6 Reads

Publication Analysis

Top Keywords

abl kinases
8
myelogenous leukemia
8
chronic myelogenous
8
abl
5
prototype tremendous
4
cellular responses
4
tremendous impact
4
responses genotoxic
4
bcr-abl imatinib
4
genotoxic stress
4
imatinib prototype
4
roles cellular
4
prominent roles
4
abl plays
4
leukemia revolutionized
4
outcomes chronic
4
plays prominent
4
stress well
4
clinical outcomes
4
impact clinical
4

References

(Supplied by CrossRef)

Similar Publications